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Humans face daunting challenges in the successful exploration and colonization of space, 
including adverse alterations in gravity and radiation. The Earth-determined biology of 
humans, animals and plants is significantly modified in such extraterrestrial environments. 
One physiological requirement shared by humans with larger plants and animals is a 
complex, highly branching vascular system that is dynamically responsive to cellular 
metabolism, immunological protection and specialized cellular/tissue function. 
 
The VESsel GENeration (VESGEN) Analysis has been developed as a mature beta 
version, pre-release research software for mapping and quantification of the fractal-based 
complexity of vascular branching. Alterations in vascular branching pattern can provide 
informative read-outs of altered vascular regulation. Originally developed for biomedical 
applications in angiogenesis, VESGEN 2D has provided novel insights into the cytokine, 
transgenic and therapeutic regulation of angiogenesis, lymphangiogenesis and other 
microvascular remodeling phenomena. Vascular trees, networks and tree-network 
composites are mapped and quantified. Applications include disease progression from 
clinical ophthalmic images of the human retina; experimental regulation of vascular 
remodeling in the mouse retina; avian and mouse coronary vasculature, and other 
experimental models in vivo. We envision that altered branching in the leaves of plants 
studied on ISS such as Arabidopsis thaliana cans also be analyzed. 
 
(Supported by NASA GRC IR&D04-54 and 2010 TTP Fund, NIH EY-01759 & 
NSF Center of Excellence, University of Washington Engineered Biomaterials) 
https://ntrs.nasa.gov/search.jsp?R=20100042235 2019-08-30T13:24:03+00:00Z
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Vascular Alterations, Immunosuppression & Bone Loss:
NASA-defined risk categories for human space exploration
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VESGEN 2D
APPLICATIONS 
Vascular Trees 
Human Retina
Avian CAM, Yolksac and Murine/Avian Coronary Vessels
Plant Leaf Venation such as in Arabidopsis thaliana?
Vascular Networks
Mouse Postnatal Retina and Intestinal Inflammation
CAM Lymphatic Vessels
Vascular Tree-Network Composites
Normal and Abnormal Embryonic Coronary Vessels
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Panel to 
specify
vessel type
Main panel
• Image specification
• Algorithm selection
• Process initiation
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Mapping and Quantification of Microvascular
Remodeling and Angiogenesis by VESGEN
1. Cells in Vitro
4. Humans
3. Blood Vessels
1. Cells in Vitro
Avian CAM
Blood Vessels Blood Vessels
Molecular Regulation Transgenic Mouse
Cells in Vitro
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VESGEN Hypothesis: ‘Signature’ Vascular Patterns
FGF-2 as a Simple Stimulator
VEGF as a Complexity Factor
TGF-β1 as a Simple Inhibitor
But Complex Potentiator
(Fibroblast Growth Factor-2)
(Vascular Endothelial Growth Factor-2)
(Transforming Growth Factor-β1)
- D’Arcy Thompson
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Arterio Scler Thromb Vasc Biol 20 2000
Microvascular Research 72(3) 2006
Microvascular Research 59(2) 2000
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Vascular pattern provides an integrative read-out of dominant 
molecular regulators in complex signaling pathways of 
angiogenesis and microvascular remodeling
VESsel GENeration (VESGEN) Analysis Software
Vessel Number Density, Nv
Vessel Length Density, Lv
Vessel Diameter, Dv
Fractal Dimension, Df
Branchpoint + Endpoint Densities, Brv+Ev
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Clinical Steroid (TA) Treatment in CAM Vascular Tree
Reviewed in Anatomical Record 2009; Investigative Ophthalmology & Visual Science 2008
8
at Lewis Field
Glenn Research Center
9
at Lewis Field
Glenn Research Center
See also Candela H et al, ‘Venation Pattern Formation in Arabidopsis thaliana Vegetative Leaves’, Developmental Biology 205:205(1999) 
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Parsons et al, Microvascular Research 167(1):193-211(2005)
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ANATOMICAL RECORD
in press
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P. Kaiser MD, Cole Eye Institute: P. Kaiser MD, Cole Eye Institute: P. Kaiser MD, Cole Eye Institute:
with J Sears & Q Ebrah m (Cole Eye I s itute), from Vickerman et al, Anatomical Record A 292(3), 2009                  
VASCULAR NETWORKS IN TRANSGENIC MOUSE RETINA
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CORONARY VESSEL NETWORK-TO-TREE TRANSITIONS
Vickerman et al, VESGEN Review, Anatomical Record A 292(3), 2009
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P Parsons-Wingerter et al IOVS 51(1) 2010 & M Vickerman et al Anat Rec 292(3) 2009
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K Radhakrishnan, P Parsons-Wingerter, M B Vickerman, P K Kaiser, IOVS 51(1):498-507 (2010) and in progress
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Parsons, Radhakrishnan, Vickerman & Kaiser, Investigative Ophthalmology & Visual Science 51(1):498-507 (2010)
Surprising Oscillation of Angiogenesis with Vascular Dropout 
during Progression of Diabetic Retinopathy
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VESGEN
as Collaborative 
Research Discovery Tool
with Biologists and Physicians
Integrative Systems Biology:
‘Fingerprint’ or ‘Signature’ Mapping of Dominant Vascular Patterns 
Induced by VEGF and Other Angiogenesis Regulators
Fractal-Based VESGEN for Multi-Parametric Pattern Analysis according to 
Branching Generation
Research Discovery Tool for
Variety of plant, animal and human applications on ISS?
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